Thomas Thomasen Durhuus

Title: Thomas Thomasen Durhuus: Innovator in Metabolically Engineered Cells

Introduction

Thomas Thomasen Durhuus is a notable inventor based in København, Denmark. He has made significant contributions to the field of biotechnology, particularly in the area of genetically engineered micro-organisms. His work focuses on the production of valuable compounds through innovative metabolic pathways.

Latest Patents

Durhuus holds a patent for "Metabolically engineered cells for the production of pinosylvin." This invention involves a genetically engineered micro-organism that has an operative metabolic pathway producing cinnamoyl-CoA, which is then used to produce pinosylvin. The process includes the formation of cinnamic acid from L-phenylalanine by a L-phenylalanine ammonia lyase (PAL). The patent highlights the specific ratios of substrate acceptance and enzyme production that optimize the efficiency of pinosylvin production.

Career Highlights

Durhuus is currently associated with Fluxome Sciences A/S, where he applies his expertise in metabolic engineering. His innovative approach has positioned him as a key player in the biotechnology sector, contributing to advancements in sustainable production methods.

Collaborations

Some of his notable coworkers include Michael Katz and Jochen Förster, who collaborate with him on various projects within the company. Their combined expertise enhances the research and development efforts at Fluxome Sciences A/S.

Conclusion

Thomas Thomasen Durhuus is a pioneering inventor whose work in metabolically engineered cells is paving the way for new biotechnological advancements. His contributions are significant in the production of valuable compounds, showcasing the potential of genetic engineering in modern science.